Table 1 Correlation between KHSRP levels in NSCLC patients and their clinicopathologic characteristics
From: RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer
Clinical pathology | KHSRP Levels | N | P Value | ||
|---|---|---|---|---|---|
Low | Middle | High | |||
Gender | |||||
Male | 5 (12.82%) | 15 (38.46%) | 19 (48.72%) | 39 | |
Female | 10 (27.78%) | 10 (27.78%) | 16 (44.44%) | 36 | 0.2338 |
Age | |||||
< 60 | 6 (20.00%) | 6 (20.00%) | 18 (60.00%) | 30 | |
≥ 60 | 9 (20.00%) | 19 (42.22%) | 17 (37.78%) | 45 | 0.2730 |
Tumor size (cm) | |||||
≤ 3 | 7 (17.07%) | 13 (31.71%) | 21 (51.22%) | 41 | |
> 3 | 8 (23.53%) | 12 (35.29%) | 14 (41.18%) | 34 | 0.4663 |
Histological grade | |||||
I- II | 2 (15.38%) | 5 (38.46%) | 6 (46.15%) | 13 | |
II | 10 (22.73%) | 15 (34.09%) | 19 (43.18%) | 44 | 0.3785 |
II - IV | 3 (16.67%) | 5 (27.78%) | 10 (55.56%) | 18 | |
Clinical Stage | |||||
T1 + T2 | 13 (5.45%) | 20 (36.36%) | 22 (40.00%) | 55 | |
T3 + T4 | 2 (10.00%) | 5 (25.00%) | 13 (65.00%) | 20 | 0.0121* |
Lymph node status | |||||
Metastasis | 2 (9.52%) | 6 (28.57%) | 13 (61.90%) | 21 | |
No metastasis | 13 (24.07%) | 19 (35.19%) | 22 (40.74%) | 54 | 0.0166* |
Carcinoma | |||||
Primary | 15 (20.00%) | 25 (33.33%) | 35 (46.67%) | 75 | |
Adjacent | 60 (80.00%) | 12 (16.00%) | 3 (4.00%) | 75 | 0.0000* |